Načítá se...
Pharmacoeconomic evaluation of costs of rheumatoid arthritis therapy with selected biological treatment
OBJECTIVES: Among autoimmune diseases, rheumatoid arthritis (RA) is the most common chronic inflammatory disease of the joints. Its pathogenesis is still not fully understood, but the gained knowledge has contributed to the development of modern treatment. The introduction of biological therapy for...
Uloženo v:
| Vydáno v: | Reumatologia |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6330685/ https://ncbi.nlm.nih.gov/pubmed/30647479 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/reum.2018.80710 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|